Related Experiment Video
Updated: Dec 24, 2025

Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
Published on: July 19, 2024
[Non-alcoholic fatty liver disease; a full-bodied epidemic]
M E Tushuizen1,2, A G Holleboom3, B G P Koot4
1LUMC, afd. Maag-, Darm- en Leverziekten, Leiden.
Non-alcoholic fatty liver disease (NAFLD) is a common condition characterized by fat accumulation in the liver. Lifestyle changes for weight reduction remain the primary treatment approach for NAFLD.
Area of Science:
- Hepatology
- Gastroenterology
- Internal Medicine
Background:
- Non-alcoholic fatty liver disease (NAFLD) is the most prevalent cause of chronic liver disease.
- NAFLD spectrum ranges from simple steatosis to non-alcoholic steatohepatitis (NASH), fibrosis, cirrhosis, and hepatocellular carcinoma.
- Pathogenesis involves genetic, metabolic, inflammatory, and environmental factors including obesity, insulin resistance, and gut microbiome.
Purpose of the Study:
- To define Non-alcoholic fatty liver disease (NAFLD).
- To outline the spectrum of NAFLD.
- To discuss the risk factors and complications of NAFLD.
Main Methods:
- Diagnosis relies on imaging or histopathological examination.
- Exclusion of secondary causes like excessive alcohol consumption or specific medications is crucial.
- Assessment of associated risk factors and potential complications.
Main Results:
- NAFLD encompasses a range of conditions from simple fatty liver to advanced liver disease.
- Associated conditions include type 2 diabetes mellitus, cardiovascular disease, and hepatocellular carcinoma.
- No specific medications are currently approved for NAFLD treatment.
Conclusions:
- NAFLD is a significant health concern with a complex etiology.
- Patients with NAFLD face increased risks for serious comorbidities.
- Lifestyle modification focusing on weight reduction is the current cornerstone of NAFLD management.
More Related Videos
08:35A Model of Experimental Steatosis In Vitro: Hepatocyte Cell Culture in Lipid Overload-Conditioned Medium
Published on: May 18, 2021
08:41Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
Published on: March 24, 2023
Related Concept Videos
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Ultrasound II: Endoscopic Ultrasound and FibroScan
Endoscopic Ultrasound (EUS):
Overview of Fatty Acid Metabolism
Fatty acids are catabolized in a process called beta-oxidation, which takes place in the matrix of the mitochondria and converts their fatty acid chains into two-carbon units of acetyl groups. The acetyl...
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Liver Physiology
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...